Search results
Results From The WOW.Com Content Network
However, the rising dividend yield seems to be just a byproduct of the market selling Pfizer stock off for its declining sales. Management even raised guidance in Q1. Management even raised ...
A high-yield dividend stock with long-term potential Pfizer's current 5.73% dividend yield stands well above the S&P 500 average of 1.35%. The company's payout ratio of 443% appears unsustainable ...
Pharmaceutical giant Pfizer (NYSE: PFE) stands out in this context. The company currently offers a mouthwatering 5.7% dividend yield -- the highest among major drug manufacturers and one of the ...
The good news on this front, though, is that Pfizer is poised to improve its bottom line and make its dividend even safer. Sure, the big pharma company's earnings fell 11% year over year in Q2.
With a lot of new drugs to sell, Pfizer expects adjusted earnings to reach a range between $2.15 and $2.35 per share this year, which is more than it needs to meet a dividend commitment currently ...
The good news is that most, if not all, of this patent risk seems baked into Pfizer's shares at this point. After falling by over 32% in the past 12 months, the pharma titan's shares are trading ...
For premium support please call: 800-290-4726 more ways to reach us
Pfizer's dividends should keep flowing and growing. Pfizer's dividends should keep flowing and growing. ... News. Science & Tech. Shopping. Sports. Weather ...